| Sunday 6 May, 2007 |
| 08:00-09:00 |
 |
Symposium 1:
Bone Growth and Modelling |
|
| 08:00 |
IS02 |
BONE GROWTH IN LENGTH AND WIDTH: THE YIN AND YANG
OF BONE STABILITY
Frank Rauch (Montreal, Canada) |
|
| 08:30 |
IS03 |
TOWARD AN EXPANDED UNDERSTANDING OF THE
ROLE OF THE PERIOSTEUM IN SKELETAL HEALTH
Eric
Orwoll (Oregon, USA) |
|
| 09:00 - 10:00 |
|
Oral
Communications 1: Bone Development and Tissue Engineering |
|
| 10:00 - 11:15 |
|
Coffee and Attended
Posters
|
|
|
| 11:15 - 12:45 |
|
Workshop 1: Implant
Loosening |
|
|
| 11:15 |
IS04 |
EPIDEMIOLOGY OF ASEPTIC LOOSENING
Ove
Furnes (Bergen, Norway) |
|
| 11:45 |
IS05 |
THE PATHOGENESIS OF OSTEOLYSIS AND IMPLANT
LOOSENING
Mark Wilkinson (Sheffield,
United Kingdom) |
|
| 12:15 |
IS06 |
BIOLOGIC TREATMENT STRATEGIES
Kjeld Søballe (University
of Aarhus, Denmark) |
|
| 11:15 - 12:45 |
|
Workshop 2: Proteomics |
|
|
| 11:15 |
IS07 |
QUANTITATIVE PROTEOMICS FOR CELL DIFFERENTIATION IN
BONE DEVELOPMENT
Irina Kratchmarova
(University of Southern Denmark) |
|
| 11:45 |
IS08 |
PROTEOMICS TECHNOLOGY
Mathias Mann (Martinsried, Germany) |
|
| 12:15 |
IS09 |
BIOMARKER DISCOVERY
Claes
Lindberg (Lund, Sweden) |
|
| 12:45 - 14:00 |
|
Lunch and Posters |
|
| 13:00 - 14:00 |
|
Meet the
Professor Sessions |
|
| 14:00 - 15:00 |
|
Symposium 2:
Epigenetics |
|
| 14:00 |
IS10 |
DEVELOPMENTAL ORIGINS OF OSTEOPOROTIC
FRACTURE: THE ROLE OF MATERNAL VITAMIN D INSUFFICIENCY
Cyrus Cooper (Southampton, United
Kingdom) |
|
| 14:30 |
IS11 |
READING THE DNA METHYLATION SIGNAL
Adrian Bird (Edinburgh, United Kingdom) |
|
| 15:00 - 15:05 |
|
Award Presentation: ECTS/AMGEN
RESEARCH FELLOWSHIP |
|
15:05-16:05
|
|
Oral
Communications 2: Osteoporosis and Genetics |
|
| 16:05-16:30 |
|
Coffee
|
|
| 16:30-17:30 |
|
Oral
Communications 3: Hormones, including Estrogen, Vitamin D, PTHRP |
|
|
| 17:30-18:00 |
|
Break |
|
18:00-19:30
|
|
Satellite Symposium 5: Can Key
Differences Among Bisphosphonates Translate Into Higher Quality Therapy
for the Osteoporosis Patient?
SUPPORTED BY THE
ALLIANCE FOR BETTER HEALTH (P&G AND SANOFI-AVENTIS) |
|
| |
|
EXPANDING THE CLINICAL EVIDENCE ON DIFFERENCES
AMONG BISPHOSPHONATES AND THE IMPORTANCE FOR RAPID ACTION IN OSTEOPOROSIS
THERAPY
Pierre Delmas (Lyons, France) |
|
| |
|
THE VALUE OF CHOICE AND FLEXIVILITY FOR
PATIENT-CENTERED OSTEOPOROSIS TREATMENT
Robert Lindsay (West Haverstraw, USA) |
|
| |
|
CONSEQUENCES OF DIFFERENCES IN STRUCTURE-FUNCTION
RELATIONSHIPS AMONG BISPHOSPHONATES
Graham Russell (Oxford, UK)
|
|
